Deyaa Adib insider trades: Fibrogen (FGEN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Deyaa reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 12, 2024 | FGEN | ↑ Buy | 22,123 | $1.17 | $26K | Direct | Jun 13, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FGEN insiders
Open-market trades in the last 12 months
About Deyaa Adib's insider trades
Deyaa Adib is Chief Medical Officer at Fibrogen (FGEN). Since Jun 12, 2024, Deyaa has reported 1 open-market purchase worth $26K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FGEN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.